Senior E&L Chemist, Analytical Services Pacific Biolabs IncSenior E&L Chemist, Analytical ServicesHercules, CA$110,000–$140,000 / yearThe highly experienced and technically adept extractables and leachables chemist will lead efforts in identifying unknown peaks in complex samples using advanced Liquid Chromatography-Mass Spectrometry (LC/MS) techniques. Collaboration and communication: Work effectively with cross-functional teams, including other instrumentation groups, and quality assurance, to communicate findings, discuss results, and provide technical support related to unknown identification.
Field Chemist II Republic Services IncField Chemist IISan Jose, CA$39.35–$54.12 / hourPOSITION SUMMARY: The Environmental Field Chemist II role works both indoors and outdoors at various customer sites as a proficient partner to the team to lead safety protocols, package all materials based on required regulations, including onsite testing of suspected materials, and work with the customer to add additional services. Required skills include performing proper waste sampling; creating accurate waste characterizations and profiles; addressing difficult situations in a constructive manner; utilizing computer technology for communication, data gathering and reporting; negotiation and problem solving.
Chemist Intern (Bachelors/Masters - Santa Clara, CA) Applied Materials IncChemist Intern (Bachelors/Masters - Santa Clara, CA)Santa Clara, CAIf you would like to contact us regarding accessibility of our website or need assistance completing the application process, please contact us via e-mail at Accommodations_Program@amat.com, or by calling our HR Direct Help Line at 877-612-7547, option 1, and following the prompts to speak to an HR Advisor. The salary offered to a selected candidate will be based on multiple factors including location, hire grade, job-related knowledge, skills, experience, and with consideration of internal equity of our current team members.
NewSenior Scientist I/II, Analytical Chemistry Actalent IncSenior Scientist I/II, Analytical ChemistryHercules, CA$55.28–$64.90 / hourWe are proud to be an Engineering News-Record (ENR) Top 500 Design Firm for our engineering design services and a ClearlyRated Best of Staffing winner for both client and talent service. If you would like to request a reasonable accommodation, such as the modification or adjustment of the job application process or interviewing process due to a disability, please email actalentaccommodation@actalentservices.com for other accommodation options.
Staff Scientist II - Medicinal Chemistry Protagonist Therapeutics IncStaff Scientist II - Medicinal ChemistryNewark, CA$135,000–$145,000 / yearThe Company also has a number of preclinical stage drug discovery programs addressing clinically and commercially validated targets including an oral IL-17 peptide antagonist, obesity dual and triple agonists, an oral hepcidin functional mimetic, and the recently announced IL-4 and amylin programs. The base pay range for this position at commencement of employment is expected to be between $135,000 and $145,000/year; however, base pay offered may vary depending on multiple individualized factors, including market location, job-related knowledge, skills, and experience.
Director, Medicinal Chemistry Protagonist Therapeutics IncDirector, Medicinal ChemistryNewark, CA$210,000–$250,000 / yearThe Discovery Chemistry team at Protagonist Therapeutics is seeking a highly motivated and experienced Director of Medicinal Chemistry to lead and manage a competent chemistry group in small molecule and peptide drug discovery against a diverse range of therapeutic targets. The Company also has a number of preclinical stage drug discovery programs addressing clinically and commercially validated targets including an oral IL-17 peptide antagonist, obesity dual and triple agonists, an oral hepcidin functional mimetic, and the recently announced IL-4 and amylin programs.
Staff / Senior Scientist, Assay Development (Chemistry) Glyphic BiotechnologiesStaff / Senior Scientist, Assay Development (Chemistry)Berkeley, CA$123,000–$187,575 / yearReporting to the Director of Assay Development, you will be a hands-on expert working at the chemistry-assay interface — developing the chemical methods that enable reliable, high-efficiency sample loading into our expansion assay, and building the novel conjugation, cleavage, and stabilization workflows that power our single-molecule proteome sequencing platform. Demonstrated experience developing site-selective bioconjugation chemistry for native peptides — including N-terminal, C-terminal, and side-chain modification strategies — using click chemistry (CuAAC, SPAAC, IEDDA), NHS-ester coupling, and related bioorthogonal approaches in multi-component peptide systems.
Process Development Engineer, Chemistry Aralez BioProcess Development Engineer, ChemistryBerkeley, CaliforniaPerform “scale-up” and “scale-down” procedures for chemical reactions and unit operations, including optimization and troubleshooting, to ensure successful and efficient transfer from lab-scale (milligram to gram) to pilot-scale (kilogram) and eventual manufacturing scale (multi-kilogram to ton). Execute various chemical unit operations (biocatalytic and chemical reactions, filtrations, purifications, etc.) to produce high-quality noncanonical amino acid products, in collaboration with the Production team.
Chemistry - Graduates - AI Training - San Jose, US Prolific Academic LtdChemistry - Graduates - AI Training - San Jose, USSan Jose, CAWe're looking for Chemistry Experts and Chemical Engineers to join our Expert Network to help train and evaluate cutting-edge AI models using real-world chemical expertise. We've built a unique platform that connects researchers and companies with a global pool of participants, enabling the collection of high-quality, ethically sourced human behavioural data and feedback.
Director, Drug Substance Revolution Medicines IncDirector, Drug SubstanceRedwood City, CA$211,000–$264,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The Opportunity: Playing a critical role as a technical lead within the Drug Substance function, the position will be responsible for process research and development and scale-up of manufacturing in support of Revolution Medicines' pipeline compound development, clinical programs and commercial readiness.
Senior Scientist II, Drug Substance Revolution Medicines IncSenior Scientist II, Drug SubstanceRedwood City, CA$170,000–$212,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The Opportunity: Playing a critical role as a technical lead within the Drug Substance function, the position will be responsible for process research and development and scale-up of manufacturing in support of Revolution Medicines' pipeline compound development, clinical programs and commercial readiness.
Senior Scientist II, Drug Substance Revolution MedicinesSenior Scientist II, Drug SubstanceRedwood City, CaliforniaThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Playing a critical role as a technical lead within the Drug Substance function, the position will be responsible for process research and development and scale-up of manufacturing in support of Revolution Medicines’ pipeline compound development, clinical programs and commercial readiness.
Director, Drug Substance Revolution MedicinesDirector, Drug SubstanceRedwood City, CaliforniaThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Playing a critical role as a technical lead within the Drug Substance function, the position will be responsible for process research and development and scale-up of manufacturing in support of Revolution Medicines’ pipeline compound development, clinical programs and commercial readiness.
R&D Scientist III Thermo Fisher Scientific IncR&D Scientist IIIFremont, CA$100,000–$133,300 / yearAt least 120 hours paid time off (PTO), 10 paid holidays annually, paid parental leave (3 weeks for bonding and 8 weeks for caregiver leave), accident and life insurance, and short- and long-term disability in accordance with company policy. Contribute to the development of high-quality assay reagents by designing and executing synthetic routes for haptens, adducts, and related intermediates.
Chemistry Teacher - .25 Time, August 2026 - June 2027 The College Preparatory SchoolChemistry Teacher - .25 Time, August 2026 - June 2027Oakland, CAPart timeTeachers thrive at College Prep when they partake in the opportunities offered by a rich co-curricular program and a tightly knit school that embraces equity and inclusiveness, and actively seeks to strengthen its ties to the greater Oakland community. Faculty at College Prep are compensated according to a step scale based on years of experience that ranges from $74,000 for teachers with no prior relevant experience to $148,500 for teachers with 44 years of prior experience.
Principal Scientist, Analytical Chemistry Revolution Medicines IncPrincipal Scientist, Analytical ChemistryRedwood City, CA$190,000–$238,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Design and implementation of discovery analytics, analytical data integration through collaboration with LabOS team, Data Sciences and Data Analytics functions to develop and implement automated high-throughput analytical methods that enhance efficiency and data quality.
Director of Formulation Chemistry MonarchDirector of Formulation ChemistryOakland, CaliforniaThen applying computational chemistry and machine learning tools to predict which of the billions of potential compounds in nature trigger a ‘fly away’ signal from the olfactory neurons in the antennae to the smell center in the animal’s brain. Monarch is developing a product that works—a spatial repellent that protects crops from insects, humans from toxins, and insects from needless harm.
Senior Product Manager, Chemistry Revolution Medicines IncSenior Product Manager, ChemistryRedwood City, CA$186,000–$233,000 / yearYou will partner with medicinal chemists, synthetic chemists, computational chemists, analytical chemists, DMPK and Biology partners, Data Science, ML Engineering, Data Engineering, IT, and platform teams to turn complex Chemistry workflows into intuitive, scalable solutions that accelerate the Design-Make-Test-Learn cycle. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Senior Product Manager, Chemistry Revolution MedicinesSenior Product Manager, ChemistryRedwood City, CaliforniaYou will partner with medicinal chemists, synthetic chemists, computational chemists, analytical chemists, DMPK and Biology partners, Data Science, ML Engineering, Data Engineering, IT, and platform teams to turn complex Chemistry workflows into intuitive, scalable solutions that accelerate the Design-Make-Test-Learn cycle. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.